4//SEC Filing
DAVIS ROBERT T. JR. 4
Accession 0000917520-24-000023
CIK 0000917520other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:22 PM ET
Size
9.0 KB
Accession
0000917520-24-000023
Insider Transaction Report
Form 4
DAVIS ROBERT T. JR.
Corp VP, Pres. Neurosurgery
Transactions
- Exercise/Conversion
Common Stock
2024-03-06$32.59/sh+8,736$284,663→ 58,241 total - Sale
Common Stock
2024-03-06$36.59/sh−8,348$305,492→ 49,893 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-03-06−8,736→ 0 totalExercise: $32.59Exp: 2024-03-14→ Common Stock (8,736 underlying)
Footnotes (3)
- [F1]Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire.
- [F2]The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016.
Documents
Issuer
INTEGRA LIFESCIENCES HOLDINGS CORP
CIK 0000917520
Entity typeother
Related Parties
1- filerCIK 0001563606
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:22 PM ET
- Size
- 9.0 KB